RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,150,880 | +36.3% | 137,443 | -2.0% | 0.00% | – |
| Q2 2023 | $2,312,245 | +16.1% | 140,221 | +25.6% | 0.00% | – |
| Q1 2023 | $1,991,532 | -36.0% | 111,633 | +4.4% | 0.00% | -100.0% |
| Q4 2022 | $3,113,394 | -17.1% | 106,916 | -30.2% | 0.00% | 0.0% |
| Q3 2022 | $3,754,000 | +957.5% | 153,213 | +79.1% | 0.00% | – |
| Q2 2022 | $355,000 | -64.1% | 85,565 | -0.3% | 0.00% | – |
| Q1 2022 | $989,000 | -86.7% | 85,811 | -88.5% | 0.00% | -100.0% |
| Q4 2021 | $7,444,000 | -32.6% | 745,883 | -11.8% | 0.00% | -50.0% |
| Q3 2021 | $11,048,000 | -56.5% | 845,952 | -34.7% | 0.00% | -50.0% |
| Q2 2021 | $25,377,000 | +17.5% | 1,296,081 | +27.7% | 0.00% | 0.0% |
| Q1 2021 | $21,595,000 | -65.4% | 1,015,302 | -51.7% | 0.00% | -66.7% |
| Q4 2020 | $62,469,000 | +21.4% | 2,101,227 | -11.5% | 0.01% | +9.1% |
| Q3 2020 | $51,452,000 | -11.2% | 2,374,348 | -8.6% | 0.01% | -15.4% |
| Q2 2020 | $57,913,000 | +42.6% | 2,596,923 | -2.7% | 0.01% | +18.2% |
| Q1 2020 | $40,611,000 | -46.7% | 2,668,228 | -19.6% | 0.01% | -31.2% |
| Q4 2019 | $76,244,000 | +216.9% | 3,320,751 | +198.0% | 0.02% | +220.0% |
| Q3 2019 | $24,059,000 | +101.5% | 1,114,347 | +105.4% | 0.01% | +66.7% |
| Q2 2019 | $11,938,000 | -24.9% | 542,630 | -6.4% | 0.00% | -25.0% |
| Q1 2019 | $15,892,000 | -1.9% | 579,779 | -3.8% | 0.00% | 0.0% |
| Q4 2018 | $16,196,000 | +50.8% | 602,514 | +63.6% | 0.00% | +100.0% |
| Q3 2018 | $10,743,000 | -4.6% | 368,290 | +2.3% | 0.00% | -33.3% |
| Q2 2018 | $11,257,000 | +3.7% | 360,075 | -34.0% | 0.00% | +50.0% |
| Q1 2018 | $10,851,000 | -31.5% | 545,256 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $15,845,000 | – | 545,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |